We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Thermo webinar Ensuring the Clinical Utility of Pharmacogenomic Tests featuring Dr. Becky Winslow

Ensuring the Clinical Utility of Pharmacogenomic Tests

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine. Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?

In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests. You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.

In this webinar, our expert speaker will:

  • Explain the ACCE Model Project Framework for evaluating genetic tests, specific to PGx tests
  • Define analytical and clinical validity and clinical utility and their importance to pharmacogenetic testing stakeholders
  • Discuss key considerations laboratorians need to ponder when implementing a PGx test that meets ACCE standards
  • Name real-world clinical PGx tests that have earned pharmacogenomics experts’ approval for their validity and utility

Dr. Becky Winslow
Dr. Becky Winslow
inGENEious Rx
Brought to you by
Register for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Want to invite a colleague?

Click the button below to begin inviting a colleague to this Webinar